Last year BKL pushed share price up by reporting quarterly as well as updates.
We share holders need to know how is the company operation going on.
Quarterly earning report needed.
- Forums
- ASX - By Stock
- A2M
- Very stupid and no brain fund managers and analysists
Very stupid and no brain fund managers and analysists, page-11
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $6.913M | 1.000M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 10516 | $6.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.88 | 10018 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 10051 | 6.870 |
26 | 17697 | 6.860 |
20 | 29399 | 6.850 |
17 | 33984 | 6.840 |
13 | 13353 | 6.830 |
Price($) | Vol. | No. |
---|---|---|
6.880 | 9908 | 11 |
6.890 | 29239 | 17 |
6.900 | 55420 | 20 |
6.910 | 79432 | 9 |
6.920 | 8919 | 7 |
Last trade - 14.47pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online